Published in Hepatitis Weekly, June 25th, 2007
Revenues were $5.5 million during the second fiscal quarter ended March 31, 2007, of which $5.0 million was from our hepatitis C virus (HCV)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.